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ABSTRACT
  
Objective: Present study aim for the purification of quantitative phytochemical compounds from roots of  Caralluma quadrangula 
belongs to the family Asclepiadaceae. This type of plants can be use as folk medicine to take care of wide diversity of health and 
diseases situation. 
Methods: Preliminary phytochemical analysis for different type of chemical compounds by using various chromatographic 
techniques. The phytochemical characterizations were evaluated by nuclear magnetic resonance and mass spectrometry. 
Results: The quantitative phytochemical analysis of this species exhibited the presence four pure compounds,  hydroxyoplopan-4-
one (4.5 mg), dihydroxyeudesm-4(15)-ene (5.0 mg), and quercetin- rhamnopyranosyl-D-glucopyranose (Rutin) (7.0 mg). 
Conclusion: From this study, it can be concluded that the species found four pure compounds from C. quadrangula.  
Keywords: Caralluma  quadrangula, hydroxyoplopan-4-one, dihydroxyeudesm-4(15)-ene, quercetin- rhamnopyranosyl- D-
glucopyranose (Rutin).   
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INTRODUCTION 
Medically significant genus Caralluma is widely 
studied for its stem and fruits. It is belong to the family 
Asclepiadaceae, which comprises 200 genera and 2500 
species1. About 200 species belong to genus Caralluma 
distributed throughout Africa and Asia. The greater 
part of species are native in Indian sub-continent and 
Arabian Peninsula2. A number of Caralluma species 
use as anti-hyperglycemic goings-on of their crude 
extracts or their corresponding fractions3,4. The 
investigation  of the chemical and biological  members 
of genus Caralluma3,5 the anti-hyperglycemic activity 
of the extracts, fractions of  the major pregnane 
glycoside of the aerial parts of C. quadrangula was 
investigated in Kingdom Saudi Arabia as  novel. We 
use the extract of C. quadrangula as herbal medicine in 
Saudi, for the treatment of freckles, diabetes, vitiligo 
and melasma and for thirst, hunger5,6. Several countries 
the species of Caralluma are fit to be eaten and variety 
division for the traditional medicine organization7. 
These plants can be use as folk medicine as remedies to 
health situation and treat large multiplicity of diseases8. 
The species of C. arabica use as traditionally for an 
emollient and diuretic In United Arab of Emirates. 
Also used to care for diabetes, hypertension and liver 
diseases. The C. Arabica flower  used for wounds and 
cuts, while the juice of the stem is given to sick people 
to speed convalescence of burns, itchy skin and 
sunburns9,10. The C. attenuate species in Indian 
(Andhra Pradesh) use for eaten raw as an anti-diabetic 
agent, although the juice of the plant beside the black 
pepper is suggested in the treatment of migraine11. The 
different applications of Caralluma plants in folk 
medicine have prompted the phytochemical and 
biological investigations of their constituents12. The 
pregnane glycosides, flavone glycosides, megastigm-
ane glycosides, bitter principles, triterpenes and 
saponins isolated from Caralluma13,14,15,16. 
 
MATERIALS AND METHODS 
Purified every one of chemical constituent by 
subsequent standard procedures17,18 and all chemicals 
used systematic Reagent evaluation. 
Plant material:- 
Roots of Caralluma quadrangula (Asclepiadaceae) 
were collected from Sana'a 2014. The plant identified 
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by Dr. Hessen Ibrahim and was deposited voucher 
sampling of plant in Herbarium, Department of 
Phytochemistry (Sana'a University). 
Extraction and Isolation:-  
Shade dried roots were crushed and sieved. Next 
powder was stored in air closing container. Than 
weighed and extracted with soxhlet extractor by using 
solvents Chloroform with consecutive solvent 
extraction. To concentrate the extracts and removal of 
final traces of solvent than vapor19,20. After that, 
recrystallization was done to purify the crude extracts. 
Melting point was taken by using Fisher-John 
apparatus. The 1H NMR and 13C NMR spectra were 
taken on Bruker 100 MHz and 400 MHz, spectrometer, 
using an internal standard like TMS.   
Extraction and isolation  
Extracted by using  Soxhlet (2 Kg) of  C. quadrangula 
roots powder  with solvents (3X, 8 hours each) and 
then  evaporated collective extracts to give a brown 
gummy residue (8 g) after than  separation and purified 
by silica gel flash column chromatography (FCC) with 
CHCl3 containing increasing percentages of MeOH as 
eluent and collected  20 ml for each fraction. Fractions 
3-10 were combined and rechromatographed by C.C. 
with CHCl3-MeOH  (8:2) to afford  JA1 (4.5 mg) 
identified as 10α- hydroxyoplopan-4-one (1), CHCl3-
MeOH  (7:3) to afford  JA3 (5.0 mg) identified as 1β, 
6α-dihydroxyeudesm-4(15)-ene (2), CHCl3-MeOH  
(6:4) to afford  JA4 (5.0 mg) identified  as  and  
CHCl3-MeOH  (3:7) to afford    JA4  (7.0 mg) 
identified as  quercetin- rhamnopyranosyl- D-
glucopyranose (Rutin) (4). NMR data used to identified 
for each pure compounds. 
 
 
Figure 1: 10α-Hydroxyoplopan-4-one (1) 
 
 1H-NMR (100 MHz, CDCl3) δ: 2.75 (1H, m, H-3), 
2.30 (3H, s, H-15), 1.50 (3H, s, H-13), 1.10 (3H, d,  H-
11), 0.87 (3H, d,  H-12)；13CNMR (MHz, CDCl3) δ: 
209.4 (C-14), 73.0 (C-8), 56.0 (C-3), 54.6 (C-9), 48.2 
(C-5), 45.8 (C-4), 41.0 (C-7), 28.6 (C-10), 27.5 (C-1), 
24.4 (C-2), 21.9 (C-6), 21.0 (C-11), 19.2 (C-13), 18.5  
(C-15), 15.0 (C-12). 
Dihydroxyeudesm-4(15)-ene (2). 1H-NMR (100 MHz, 
CDCl3) δ: 5.10 (1H, brs, H-15), 5.01 (1H, brs, H-15), 
3.79 (1H, t,  H-6β), 3.42 (1H, dd,  H-1α), 2.33 (1H, 
ddd,  H-3α), 2.24 (1H, sept,  H-11), 2.07 (1H, ddd, H-
3β), 1.91 (1H, s, H-8), 1.85 (1H, ddd, H-2α), 1.75 (1H, 
brd, H-5α), 1.53 (1H, m, H-2β), 1.53 (1H, m, H-8), 
1.43 (1H, brs, 1-OH), 1.28 (1H, m, H-7α), 1.20 (1H, m, 
H-9a), 1.18 (1H, m, H-9b), 1.02 (3H, d,  H-13), 0.87 
(3H, d,  H-12), 0.72 (3H, s, H-14)；13C-NMR (MHz, 
CDCl3) δ: 147.4 (C-4), 108.2 (C-15), 79.1 (C-1), 67.8 
(C-6), 56.4 (C-5), 50.1 (C-7), 42.1 (C-10), 36.9 (C-9), 
36.1 (C-3), 32.2 (C-2), 26.5 (C-11), 21.8 (C-13), 19.1 
(C-8), 16.6  (C-12), 12.0 (C-14).  
 
Figure 2: dihydroxyeudesm-4(15)-ene (2) 
 
Quercetin-L-rhamnopyranosyl-(1→6)-Dglucopyra-
nose (3). 1H NMR ( 100 MHz, CDCl3): δ 6.22 (1H, d, 
H-6), 6.40 (1H, d, H-8), 7.68 (1H, s, H-2'), 6.90 (1H, d, 
H-5'), 7.59 (1H, d, H-6' ), 5.10 ( 1H, d, Hglc-1), 3.49 
(1H, m, Hglc-2), 3.43,(1H,  m, Hglc-3), 3.50 (1H,  m, 
Hglc 4), 3.58 (1H, m, Hglc-5),  3.30 (2H, m, Hglc -6), 
4.51 (1H, br, HRha-1), 3.10 (1H, m, HRha-2), 3.43 (1H, 
m, HRha-3), 3.54 (1H, m, HRha-4), 3.31 (1H, m, HRha-5), 
1.17 (3H, d, HRha-6). 
13C NMR (CDCl3): δ 158.1 (C-2), 
135.1 (C-3), 180.0 (C-4), 160.0 (C-5), 100.0(C-6), 
166.1 (C-7), 95.1  (C-8), 163.0 (C-9), 104.7 (C-10), 
123.0 (C-1'), 118.2 (C-2'), 146.1 (C-3'), 150.1 (C-4'), 
115.8 (C-5'), 123.4 (C-6'),  105.0 (CGlc-1), 75.6  (CGlc-
2), 77.8 (CGlc-3), 74.9 (CGlc-4), 77.2 (CGlc-5), 69.0 
(CGlc-6), 103.1 (CRha-1), 71.2 (CRha-2),  72.1 (CRha-3), 
74.1 (CRha-4), 70.4 (CRha-5), 19.2 (CRha-6).   
      
Figure 3: Quercetin -rhamnopyranosyl-D-
glucopyranose 
 
 
Figure 4: H
1
 NMR of 10α- hydroxyoplopan-4-one (1) 
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Figure 5: 
13
C NMR of 10α- hydroxyoplopan-4-one (1) 
 
Figure 6: H
1
 NMR Of dihydroxyeudesm-4(15)-ene (2) 
 
Figure 7: 
13
C NMR of dihydroxyeudesm-4(15)-ene (2) 
 
RESULTS AND DISCUSSION 
Compound 1: The 1H NMR showed  one multiplet 
proton at δH 2.75 (1H, m), 5.46, High intensity Peaks 
at δ 2.30, 1.50, 1.10 and 0.88 are corresponding to 
methyl groups (Me- (15, 13, 14 and 12). 4 methyl, 4 
methylene, 5 methine and 2 quaternary carbons 
presence in  13C NMR spectrum . Carboxylic group 
signals become visible at δ 209.5. In addition of β-
hydroxyl group to C8 is visible from a peak at δ 73.1. 
hydroxyoplopan-4-one,  it has never been isolated 
before from Caralluma  quadrangula, it reported from 
Cassia buds21.  
Compound 2:  The 1H NMR showed signals for three 
angular methyl singlet's at δH 0.95, 0.85 and 0.71.  
proton of H-6 and H-1  appeared at δ 3.79 and 3.42.  
Olefinic protons present at δ 5.10 and 4.95 for H-15. 
13C NMR showed fifty carbon signal including three 
CH3, five CH2, five CH and two quaternary carbons. 
The double bond carbons appeared at δ 147.4 and 
108.1. The significant signal for the 1β, 6α-
dihydroxyeudesm-4(15)-ene would be the signals for 
two carbon attached to hydroxyl group, which is C-1 
and C-6 that appeared at δ79.2 and 67.822,23.    
 
Figure 8: H
1
 NMR of quercetin -rhamnopyranosyl-D-glucopyranose (3) 
 
 
Figure 9: 13C NMR of quercetin -rhamnopyranosyl-D-glucopyranose (3) 
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Compound 3: The 1H NMR spectrum exhibited 
signals which were typical of a flavone compound. In 
addition to the presence of five aromatic protons; one 
was represented by two meta-coupled protons at δH 
6.23 (d, H-6) and 6.42 (d, H-8). 13C NMR experiments 
showed one methyl, 15 methines, one methylene and 
10 quaternary carbon atoms, one being the flavone 
carbonyl (C 180.0)24. NMR spectral data confirmed the 
sugar part assigned as glucose and rhamnose. A 
significant downfield shift of the methylene carbon 
appearing at C 69.1 and assigned to C-6 of glucose, 
indicated a (1 to 6) type of interglycosidic linkage to 
the rhamnose moiety. Qercetin-rhamnopyranosyl-D-
glucopyranose isolated from C. quadrangula  for first 
time , it was reported in many plants as Taverniera 
aegyptiaca25,26. 
 
CONCLUSION 
The isolation and identification 10α- hydroxyoplopan-
4-one, dihydroxyeudesm-4(15)-ene, and quercetin-
rhamnopyranosyl- D-glucopyranose (Rutin),    from  
the roots of  C.  quadrangula. The work was carried 
out by means of various physical (solvent extraction, 
column chromatography, radial chromatography, 
preparative thin layer chromatography and melting 
points) and spectral techniques. 
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